Literature DB >> 14560058

A method for estimating duration of illness in Alzheimer's disease.

Rachelle Smith Doody1, J Kay Dunn, Eugene Huang, Shaheda Azher, Maria Kataki.   

Abstract

BACKGROUND: We developed a set of questions for generating an estimate regarding the date of first symptoms to the nearest half-year. Physicians then revised this estimate in conjunction with medical record review and patient/informant interviews, and by testing the estimate by recall of life events. One experienced examiner rated 36 patients, and each was independently rated by a second, less experienced rater. The physician ratings were compared to each other and to an unstructured caregiver estimate of duration using Lin concordance coefficients. There was excellent agreement between independent physician raters (rho = 0.95, p < 0.001). Caregiver estimates of duration were usually shorter because of failure to relate the first symptoms to the onset of disease. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14560058     DOI: 10.1159/000074078

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  17 in total

1.  A hidden Markov model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified.

Authors:  Julia S Benoit; Wenyaw Chan; Sheng Luo; Hung-Wen Yeh; Rachelle Doody
Journal:  Stat Med       Date:  2016-01-18       Impact factor: 2.373

2.  Ordered subset analysis of copy number variation association with age at onset of Alzheimer's disease.

Authors:  Kinga Szigeti; Blanka Kellermayer; Jenna M Lentini; Brian Trummer; Deepika Lal; Rachelle S Doody; Li Yan; Song Liu; Changxing Ma
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Olfactory copy number association with age at onset of Alzheimer disease.

Authors:  C A Shaw; Y Li; J Wiszniewska; S Chasse; S N Y Zaidi; W Jin; B Dawson; K Wilhelmsen; J R Lupski; J W Belmont; R S Doody; K Szigeti
Journal:  Neurology       Date:  2011-04-12       Impact factor: 9.910

Review 4.  Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.

Authors:  Davis C Ryman; Natalia Acosta-Baena; Paul S Aisen; Thomas Bird; Adrian Danek; Nick C Fox; Alison Goate; Peter Frommelt; Bernardino Ghetti; Jessica B S Langbaum; Francisco Lopera; Ralph Martins; Colin L Masters; Richard P Mayeux; Eric McDade; Sonia Moreno; Eric M Reiman; John M Ringman; Steve Salloway; Peter R Schofield; Reisa Sperling; Pierre N Tariot; Chengjie Xiong; John C Morris; Randall J Bateman
Journal:  Neurology       Date:  2014-06-13       Impact factor: 9.910

5.  Predictive utility of type and duration of symptoms at initial presentation in patients with mild cognitive impairment.

Authors:  Deidre J Devier; Nicole Villemarette-Pittman; Patrick Brown; Gregory Pelton; Yaakov Stern; Mary Sano; D P Devanand
Journal:  Dement Geriatr Cogn Disord       Date:  2010-09-15       Impact factor: 2.959

6.  Vitamin E use is associated with improved survival in an Alzheimer's disease cohort.

Authors:  Valory N Pavlik; Rachelle S Doody; Susan D Rountree; Eveleen J Darby
Journal:  Dement Geriatr Cogn Disord       Date:  2009-12-10       Impact factor: 2.959

7.  Predicting progression of Alzheimer's disease.

Authors:  Rachelle S Doody; Valory Pavlik; Paul Massman; Susan Rountree; Eveleen Darby; Wenyaw Chan
Journal:  Alzheimers Res Ther       Date:  2010-02-23       Impact factor: 6.982

8.  Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease.

Authors:  Susan D Rountree; Wenyaw Chan; Valory N Pavlik; Eveleen J Darby; Samina Siddiqui; Rachelle S Doody
Journal:  Alzheimers Res Ther       Date:  2009-10-21       Impact factor: 6.982

9.  Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.

Authors:  Kinga Szigeti; Deepika Lal; Yanchun Li; Rachelle S Doody; Kirk Wilhelmsen; Li Yan; Song Liu; Changxing Ma
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  CSF prion protein concentration and cognition in patients with Alzheimer disease.

Authors:  Christian Schmidt; Svetlana Artjomova; Martin Hoeschel; Inga Zerr
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.